Insider Transactions in Q1 2025 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2025
|
David R Ebsworth Director |
SELL
Bona fide gift
|
Direct |
64,000
-4.57%
|
-
|
|
Feb 26
2025
|
David R Ebsworth Director |
BUY
Exercise of conversion of derivative security
|
Direct |
460,000
+8.45%
|
$460,000
$1.47 P/Share
|
|
Feb 03
2025
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,240
-1.22%
|
$232,680
$7.16 P/Share
|
|
Feb 03
2025
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
166,888
-1.24%
|
$1,168,216
$7.16 P/Share
|
|
Feb 03
2025
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
166,728
-1.16%
|
$1,167,096
$7.16 P/Share
|
|
Feb 01
2025
|
Kathleen A. Rickard Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+1.8%
|
-
|
|
Feb 01
2025
|
Mark W Hahn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+1.46%
|
-
|
|
Feb 01
2025
|
David Zaccardelli President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+1.37%
|
-
|